Reduced Bone Mineral Density in Human Immunodeficiency Virus-infected Individuals: a Meta-analysis of Its Prevalence and Risk Factors: Supplementary Presentation
Overview
Orthopedics
Authors
Affiliations
A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in human immunodeficiency virus (HIV)-infected individuals. The prevalence of osteopenia/osteoporosis in HIV-infected and antiretroviral therapy (ART)-treated individuals was significantly higher than respective controls. Evidence regarding bone loss within first year of HIV infection or ART initiation was preliminary.
Effect of Oral Bisphosphonates on Vertebral Fractures in Males Living with HIV: A Seven Year Study.
Pezzaioli L, Porcelli T, Delbarba A, Tiecco G, Castelli F, Cappelli C J Clin Med. 2024; 13(21).
PMID: 39518665 PMC: 11546889. DOI: 10.3390/jcm13216526.
Nutritional and Lifestyle Therapy for NAFLD in People with HIV.
Cinque F, Cespiati A, Lombardi R, Guaraldi G, Sebastiani G Nutrients. 2023; 15(8).
PMID: 37111209 PMC: 10140991. DOI: 10.3390/nu15081990.
Ahmed M, Mital D, Abubaker N, Panourgia M, Owles H, Papadaki I Microorganisms. 2023; 11(3).
PMID: 36985362 PMC: 10052733. DOI: 10.3390/microorganisms11030789.
Lan K, Wang L, Lin Y, Hung K, Wu L, Ho C Nutrients. 2022; 14(17).
PMID: 36079812 PMC: 9459983. DOI: 10.3390/nu14173556.
Unravelling hip-spine bone mineral density discordance in people living with HIV.
Vizcarra P, Rosillo M, Del Rey J, Moreno A, Vivancos M, Casado J J Bone Miner Metab. 2022; 40(6):990-997.
PMID: 36038672 DOI: 10.1007/s00774-022-01365-z.